Reference - Detail
RRC ID | 55048 |
---|---|
Author | Dancy BM, Crump NT, Peterson DJ, Mukherjee C, Bowers EM, Ahn YH, Yoshida M, Zhang J, Mahadevan LC, Meyers DJ, Boeke JD, Cole PA. |
Title | Live-cell studies of p300/CBP histone acetyltransferase activity and inhibition. |
Journal | Chembiochem |
Abstract |
Histone acetyltransferase enzymes (HATs) are important therapeutic targets, but there are few cell-based assays available for evaluating the pharmacodynamics of HAT inhibitors. Here we present the application of a FRET-based reporter, Histac, in live-cell studies of p300/CBP HAT inhibition, by both genetic and pharmacologic disruption. shRNA knockdown of p300/CBP led to increased Histac FRET, thus suggesting a role for p300/CBP in the acetylation of the histone H4 tail. Additionally, we describe a new p300/CBP HAT inhibitor, C107, and show that it can also increase cellular Histac FRET. Taken together, these studies provide a live-cell strategy for identifying and evaluating p300/CBP inhibitors. |
Volume | 13(14) |
Pages | 2113-21 |
Published | 2012-9-24 |
DOI | 10.1002/cbic.201200381 |
PMID | 22961914 |
PMC | PMC3517098 |
MeSH | Acetylation Animals COS Cells Cell Survival / drug effects Chlorocebus aethiops Enzyme Inhibitors / chemical synthesis Enzyme Inhibitors / chemistry Enzyme Inhibitors / pharmacology Fluorescence Resonance Energy Transfer RNA Interference RNA, Small Interfering / metabolism Recombinant Proteins / antagonists & inhibitors Recombinant Proteins / genetics Recombinant Proteins / metabolism p300-CBP Transcription Factors / antagonists & inhibitors* p300-CBP Transcription Factors / genetics p300-CBP Transcription Factors / metabolism |
IF | 2.641 |
Times Cited | 33 |
Resource | |
DNA material | Histac pcDNA3.1 (RDB12840) |